Our vision is to defeat cancer and advance health equity for ALL communities through patient-centric social innovation and intentional, mission-aligned impact investing.
BrightEdge exists to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity
BrightEdge is led by a world-class team of investors, operators, and entrepreneurs to accelerate the commercialization of the breadth of solutions needed to target cancer from all perspectives.